TE_30831
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MIRb |
|---|---|
| TE superfamily | L2-end |
| TE class | SINE |
| Gene | NPIPA3 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 0.02 |
| Counts of samples | TCGA_tumor:0; TCGA_normal:0; GTEx:48 |
| TSS | chr16(+):14708686 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_30831.1 | NPIPA3 | Annoated | Non-coding | Non-coding | chr16(+):14708687,14708743,14708906,14709063,14716068,14716196,14719827,14719926,14720090,14720234,14723192,14723299,14724318,14724378,14724488,14724523,14725883,14725903 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
